Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma

BACKGROUND: Reduced bone mineral density (BMD) is a significant sequelae in children receiving chemotherapy for acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). Reduced BMD is associated with an increased risk for fractures. Pamidronate, a second-generation bisphosphonate, has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae Min, Kim, Ji Eun, Bae, Soon Hwan, Hah, Jeong Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698414/
https://www.ncbi.nlm.nih.gov/pubmed/23826578
http://dx.doi.org/10.5045/br.2013.48.2.99

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698414/
https://www.ncbi.nlm.nih.gov/pubmed/23826578
http://dx.doi.org/10.5045/br.2013.48.2.99

Ejemplares similares